KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive Genetic Test
Welcome to the DNA Labs UAE blog, where we provide detailed information about genetic testing and disorders. In this blog post, we will discuss the KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive Genetic Test.
Test Name: KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information
Before undergoing the KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the disorder.
Test Details
The KIF1C gene is associated with a genetic disorder called spastic ataxia type 2, which is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify mutations or variations in those genes. In the case of spastic ataxia type 2, NGS genetic testing can be used to identify mutations in the KIF1C gene that may be responsible for the disorder.
By identifying specific mutations in the KIF1C gene, NGS genetic testing can help confirm a diagnosis of spastic ataxia type 2 and provide valuable information for genetic counseling and family planning. It can also assist in determining the prognosis and potential treatment options for affected individuals.
Test Name | KIF1C Gene Spastic ataxia type 2 autosomal recessive Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KIF1C Gene Spastic ataxia type 2, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1C Gene Spastic ataxia type 2, autosomal recessive |
Test Details |
The KIF1C gene is associated with a genetic disorder called spastic ataxia type 2, which is inherited in an autosomal recessive manner. Autosomal recessive means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify mutations or variations in those genes. In the case of spastic ataxia type 2, NGS genetic testing can be used to identify mutations in the KIF1C gene that may be responsible for the disorder. By identifying specific mutations in the KIF1C gene, NGS genetic testing can help confirm a diagnosis of spastic ataxia type 2 and provide valuable information for genetic counseling and family planning. It can also assist in determining the prognosis and potential treatment options for affected individuals. |